Engineered Extracellular Vesicles for Tissue Repair and Regeneration

The document explores the potential of engineered extracellular vesicles (EVs) in tissue repair and regeneration, highlighting their ability to deliver bioactive molecules to target cells, thus enhancing therapeutic effects. Engineered EVs, particularly those derived from mesenchymal stem cells, show promise in treating conditions like ischemic stroke, osteoporosis, and hair loss, offering advantages over traditional therapies due to reduced immune response and safety. A clinical study with seven COVID-19 patients demonstrated improved lung conditions using aerosolized exosomes. Despite these promising results, challenges in clinical application remain, necessitating further research to optimize EV-based therapies for regenerative medicine.